Evidence map›Paper›PMID 23457120›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2013

Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Wenda Wu, Melissa A Bates, Steven J Bursian, Brenna Flannery, Hui-Ren Zhou, Jane E Link, Haibin Zhang, James J Pestka

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Vitamin 25(OH)DToxins · 2024
    Article
  3. Article
  4. Neither GLP-1 receptors nor GFRAL neurons are required for aversive or anorectic response to DON (vomitoxin).American journal of physiology. Regulatory, integrative and comparative physiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Calcium-Sensing Receptor and Transient Receptor Ankyrin-1 Mediate Emesis Induction by Deoxynivalenol (Vomitoxin).Toxicological sciences : an official journal of the Society of Toxicology · 2017
    Article
  18. Article
  19. Modeling the emetic potencies of food-borne trichothecenes by benchmark dose methodology.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Wenda WuCollege of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, P.R. China.
Melissa A Bates
Steven J Bursian
Brenna Flannery
Hui-Ren Zhou
Jane E Link
Haibin Zhang
James J Pestka
Unité de Nutrition Humaine · FRLaboratoire d’immunologie intégrative du cancer · FRMichigan State University · USNanjing Agricultural University · CN

Funding

NIEHS NIH HHS ES03553
6 · The paper itself

Abstract

Deoxynivalenol (DON, vomitoxin), a trichothecene mycotoxin produced by Fusarium sp. that frequently occurs in cereal grains, has been associated with human and animal food poisoning. Although a common hallmark of DON-induced toxicity is the rapid onset of emesis, the mechanisms for this adverse effect are not fully understood. Recently, our laboratory has demonstrated that the mink (Neovison vison) is a suitable small animal model for investigating trichothecene-induced emesis. The goal of this study was to use this model to determine the roles of two gut satiety hormones, peptide YY3-36 (PYY3-36) and cholecystokinin (CCK), and the neurotransmitter 5-hydroxytryptamine (5-HT) in DON-induced emesis. Following ip exposure to DON at 0.1 and 0.25mg/kg bw, emesis induction ensued within 15-30min and then persisted up to 120min. Plasma DON measurement revealed that this emesis period correlated with the rapid distribution and clearance of the toxin. Significant elevations in both plasma PYY3-36 (30-60min) and 5-HT (60min) but not CCK were observed during emesis. Pretreatment with the neuropeptide Y2 receptor antagonist JNJ-31020028 attenuated DON- and PYY-induced emesis, whereas the CCK1 receptor antagonist devezapide did not alter DON's emetic effects. The 5-HT3 receptor antagonist granisetron completely suppressed induction of vomiting by DON and the 5-HT inducer cisplatin. Granisetron pretreatment also partially blocked PYY3-36-induced emesis, suggesting a potential upstream role for this gut satiety hormone in 5-HT release. Taken together, the results suggest that both PYY3-36 and 5-HT play contributory roles in DON-induced emesis.

Indexed as

AnimalsAntiemeticsBenzamidesCholecystokininDevazepideDisease Models, AnimalDose-Response Relationship, DrugFemaleGranisetronMinkPeptide FragmentsPeptide YYPiperazinesSerotoninSerotonin AntagonistsTime FactorsAntiemeticsBenzamidesCholecystokinindeoxynivalenolDevazepideGranisetronJNJ-31020028Peptide FragmentsPeptide YYpeptide YY (3-36)PiperazinesSerotoninSerotonin AntagonistsTrichothecenes

Identifiers

PMID23457120
PMCPMC3627556
OpenAlexW2117449158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.